Glaxo to Begin Posting Drug Trial Results
511003
GlaxoSmithKline is expected to start the process of publicly posting the results of clinical trials for its marketed drugs.
6408
GlaxoSmithKline has agreed to disclose information on all clinical studies of its drugs to settle a lawsuit that accused it of withholding negative information about the antidepressant Paxil, the New York Attorney General&#39;s office says
203734
GlaxoSmithKline Plc  has signed a  drug discovery deal with U.S. biotech firm ChemoCentryx  potentially worth up to $1.5 billion in milestone payments and  research funding to the privately owned group.
110931
na settlement that the New York State attorney general said would transform the drug industry, GlaxoSmithKline agreed today to post on its Web site the results of all clinical trials involving its drugs.
315747
GlaxoSmithKline Plc GSK.L has agreed  to release all clinical studies of its drugs to settle a  lawsuit that accused it of withholding negative information  about the antidepressant Paxil, the New York Attorney General's  office said on Thursday.
534985
Early results from a new study of GlaxoSmithKline Plc's diabetes drug Avandia showed no difference in the risk of heart problems between patients taking the controversial drug and those who took other diabetes drugs, researchers said on Tuesday.
476254
GlaxoSmithKline Plc, Europe&#39;s largest drugmaker, said it settled a lawsuit filed by New York Attorney General Eliot Spitzer, who accused the drugmaker last June of withholding safety data on the antidepressant Paxil.
449256
GlaxoSmithKline PLC, the world's second-largest drug maker, began a campaign to challenge a report that linked its diabetes drug Avandia to heart risks and caused its stock to decline 11 percent in the eight days through Tuesday. The shares rose yesterday.
600885
GlaxoSmithKline, Europe's biggest drug maker, has booked a 14.9-percent increase in net profits for 2006, buoyed by soaring sales in the United States and despite a poor performance in Europe.
273264
NEW YORK, Aug. 26 -- Drugmaker GlaxoSmithKline agreed Thursday to settle charges that it hid and misrepresented unfavorable data about the effectiveness and safety of its top-selling anti-depressant Paxil for children and adolescents, agreeing to post all clinical trial data on its drugs by the end of 2005.
502254
The European Medicines Agency has  recommended conditional approval of GlaxoSmithKline Plc's new  breast cancer pill Tykerb, Europe's biggest drugmaker said on  Friday.
470908
Six months after the drug industry vowed to make its clinical trials more transparent, and three months after launching a common website to give the public "unprecedented access" to studies both good and bad, drug companies have posted unpublished trial results on the site for just five drugs.
610555
The global pharmaceutical industry unveiled plans on Thursday to publish more data about trials of medicines in a bid to reassure patients following recent alarms over drug safety.
187735
The European Medicines Agency has recommended conditional approval of GlaxoSmithKline Plc's new breast cancer pill Tykerb, Europe's biggest drugmaker said on Friday.
727578
GlaxoSmithKline PLC agreed Thursday to release information on its drug studies, including negative findings on the antidepressant Paxil, to settle a lawsuit in which New York&#39;s attorney general accused the company of fraud.
347692
GlaxoSmithKline yesterday said it would publish all details of its clinical drug trials after being accused of concealing information that its leading antidepressant could be harmful to children.
389904
LOS ANGELES (CBS.MW) - US-traded shares of GlaxoSmithKline were up Thursday as the drugmaker reported a settlement of a lawsuit filed by New York state over disclosure of Paxil test results on minors.